| 000 | 01825 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514161633.0 | ||
| 264 | 0 | _c20040105 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a1499-3872 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Shi-Chun | |
| 245 | 0 | 0 |
_aDynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. _h[electronic resource] |
| 260 |
_bHepatobiliary & pancreatic diseases international : HBPD INT _cMay 2003 |
||
| 300 |
_a196-201 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamivudine _xtherapeutic use |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xvirology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aYan, Lu-Nan | |
| 700 | 1 | _aLi, Bo | |
| 700 | 1 | _aMa, Yu-Kui | |
| 700 | 1 | _aLiu, Chong | |
| 700 | 1 | _aWen, Tian-Fu | |
| 700 | 1 | _aLin, Qi-Yuan | |
| 700 | 1 | _aZhao, Ji-Chun | |
| 700 | 1 | _aWang, Xiao-Bo | |
| 700 | 1 | _aLi, Xiao-Dong | |
| 700 | 1 | _aQing, Shan | |
| 700 | 1 | _aZhao, Lian-Shan | |
| 700 | 1 | _aLiu, Chong | |
| 700 | 1 | _aLiu, Juan | |
| 700 | 1 | _aZhang, Xiu-Hui | |
| 773 | 0 |
_tHepatobiliary & pancreatic diseases international : HBPD INT _gvol. 2 _gno. 2 _gp. 196-201 |
|
| 999 |
_c14337871 _d14337871 |
||